What does 180 life sciences do?

180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of drug candidates in the areas of inflammatory diseases, fibrosis, and pain.

What is 180 Life Sciences Corp's stock worth?

180 Life Sciences Corp. (NASDAQ:ATNF) COO Quan Anh Vu acquired 8,000 shares of the companys stock in a transaction dated Thursday, December 16th. The shares were bought at an average cost of $3.98 per share, with a total value of $31,840.00.

What is life180?

LIFE180 is all about helping entrepreneurs Live Intentionally For Excellence (LIFE). Even if you are having success, we find that most entrepreneurs can create more profit and impact more lives by improving at least one of the following areas: Implementing the Dream 100 Business Development Strategy.

Should you buy 180 life sciences (LVS) ahead of its pharmaceutical competitors?

As a group, “Pharmaceutical preparations” companies have a potential upside of 100.30%. Given 180 Life Sciences’ rivals stronger consensus rating and higher probable upside, analysts clearly believe 180 Life Sciences has less favorable growth aspects than its rivals.